Abbott Laboratories

ABT

US0028241000

Medical Equipment, Supplies & Distribution

Market Closed - Nyse Other stock markets 04:00:02 2024-04-26 pm EDT			5-day change	1st Jan Change
107.5 ^USD	+0.63%		+0.23%	-2.31%

Apr. 26	Dexcom's profit beats estimates on strong glucose monitor demand	RE
Apr. 26	Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	RE

ABBOTT LABORATORIES : Change in Directors or Principal Officers (form 8-K)

February 11, 2020 at 05:22 pm EST

brli:context>

id="From2020-02-062020-02-07_us-gaap_CommonStockMember_exch_XCHI">

scheme="http://www.sec.gov/CIK">0000001800

dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonStockMember

dimension="dei:EntityListingsExchangeAxis">exch:XCHI


        2020-02-06
        2020-02-07id="From2020-02-062020-02-07_us-gaap_CommonStockMember_exch_XNYS">


scheme="http://www.sec.gov/CIK">0000001800
 Share
        

                                            © Acquiremedia - 2020

Latest news about Abbott Laboratories

Dexcom's profit beats estimates on strong glucose monitor demand	Apr. 25	RE
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength	Apr. 25	RE
Daiwa Securities Trims Abbott Laboratories Price Target to $125 From $126	Apr. 23	MT
Barclays Adjusts Abbott Laboratories' Price Target to $140 From $141, Maintains Overweight Rating	Apr. 22	MT
UBS Raises Abbott Laboratories Price Target to $143 from $136, Buy Rating Kept	Apr. 19	MT
Correction to Health Care Roundup Article	Apr. 18	DJ
RBC Lowers Price Target on Abbott Laboratories to $125 From $128, Keeps Outperform Rating	Apr. 18	MT
Raymond James Adjusts Abbott Laboratories' Price Target to $124 From $127, Keeps Outperform Rating	Apr. 18	MT
Health Care Down After Abbott Earnings -- Health Care Roundup	Apr. 17	DJ
Sector Update: Health Care Stocks Retreating Late Afternoon	Apr. 17	MT
News Highlights : Top Company News of the Day - Wednesday at 3 PM ET	Apr. 17	DJ
S&P 500, Nasdaq dip as interest rate concerns, earnings weigh	Apr. 17	RE
Abbott Laboratories Raises Midpoint of 2024 Guidance After First-Quarter Beat	Apr. 17	MT
Top Stories at Midday: U.S. Bancorp, Abbott, Citizens Financial, First Horizon, Prologis, ASML, Travelers Report Earnings; Tesla Asks Shareholders Vote on Musk's Compensation; Eli Lilly Sleep Apnea Drug Trials Hit Primary Endpoints	Apr. 17	MT
News Highlights : Top Company News of the Day - Wednesday at 1 PM ET	Apr. 17	DJ
News Highlights : Top Company News of the Day - Wednesday at 11 AM ET	Apr. 17	DJ
Wall St slips as dour earnings, chip stocks weigh	Apr. 17	RE
Sector Update: Health Care Stocks Advance Premarket Wednesday	Apr. 17	MT
News Highlights : Top Company News of the Day - Wednesday at 9 AM ET	Apr. 17	DJ
Transcript : Abbott Laboratories, Q1 2024 Earnings Call, Apr 17, 2024	Apr. 17
Abbott: target ranges for 2024 tightened upwards	Apr. 17	CF
Abbott Laboratories' Q1 Adjusted Earnings Down, Revenue Up; 2024 Outlook Narrowed	Apr. 17	MT
Earnings Flash (ABT) ABBOTT Posts Q1 Revenue $9.96B, vs. Street Est of $9.87B	Apr. 17	MT
Earnings Flash (ABT) ABBOTT Posts Q1 EPS $0.98, vs. Street Est of $0.95	Apr. 17	MT
Abbott Laboratories Reports Earnings Results for the First Quarter Ended March 31, 2024	Apr. 17	CI

Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - diagnostic systems and instruments (39.1%); - vascular devices (24.7%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - nutrition products (12.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (8.2%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc.; - other (15.9%). Net sales are distributed geographically as follows: the United States (38.5%), Germany (5.8%), China (5.6%), India (4.4%), Switzerland (4.1%), Japan (3.8%), Netherlands (2.7%) and others (35.1%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-07-17 - Q2 2024 Earnings Release (Projected)

Related indices

S&P 500

More about the company

Income Statement Evolution

More financial data

Ratings for Abbott Laboratories

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

107.5 USD

Average target price

126.3 USD

Spread / Average Target

+17.49%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
TERUMO CORPORATION	+12.96%	24.62B
ZIMMER BIOMET HOLDINGS, INC.	-1.93%	24.52B

Other Medical Equipment, Supplies & Distribution